BY Katie Dahler, National Life Sciences Leader, KPMG   As demand for pharmaceutical cost containment intensifies, novel drug-pricing approaches are critical.   First, an unprecedented number of blockbuster drugs came off patent over the last decade, and manufacturers were not able to pump out new drug innovations fast enough to replace them. The result was that sales and profit growth for most major pharmaceutical companies fell from double digits to low single digits. Although many...

BY Catherine Lightfoot, CPA, CHBC, Director of Healthcare, EEPB Why it might be worth owning rather than leasing in this economic climate Delivering care is the primary and extremely demanding business of any healthcare provider.  So, why would you even consider owning your own real estate? Isn’t it just easier to lease? Well, like any debate, there are pros and cons to either side of the argument. This article attempts to answer the question of...

BY Eric Gorman, Principal, U.S. Lead, and Philip Glock, Partner – Co-Leader, Legal Operations Transformation Services (LOTS), KPMG When mass legal procedures emerge — whether due to a product defect, service disruption, or other liability — in-house legal teams can find themselves at the center of one of the most high-risk, high-stakes, and complex situations that can threaten a corporation. Not only does the legal team have to quickly understand and manage the legal issues,...

By Catherine Lightfoot, Director of Healthcare, EEPB   When a physician embarks upon succession planning with regard to his or her practice, it should also include careful consideration of buy/sell (a.k.a. buy-in/buy-out) agreements. What to include. What to watch out for. When and how to execute. Both scenarios require professional assistance (legal and/or accounting) to ensure proper and thorough planning in the present, with provisions to modify in the future as things change…and they always...

BY Mary Van Beusekom, MS, CIDRAP Recent studies describe how the COVID-19 pandemic cratered the finances of many US hospitals, one finding that most federal relief funds went to the already best-resourced facilities and the other two showing the devastating monetary effects of delaying or canceling surgeries. Wide disparities in fund allocation RAND Corp. researchers traced High-Impact Distribution Coronavirus Aid, Relief, and Economic Security (CARES) Act funding to 952 hospitals. Data, which were taken from...

By Catherine Lightfoot, CPA, CHBC, Director of Healthcare at EEPB In the early days of the COVID-19 pandemic, innovative Telehealth strategies took off by necessity, as patients felt more comfortable visiting with their primary care physician from the safety of their own homes. The remote delivery of medical services continues to be an opportunity to build revenue and retain those patients who still opt for Telemedicine as a preferred mode. According to a study by...

By Dion Sheidy, Partner, Healthcare Industry Leader, KPMG The COVID-19 outbreak has had a profound impact on healthcare. Across the U.S., hospitals have been converted to COVID-19 treatment centers, and elective procedures have been put on hold by government mandate. Although CARES Act funds will help health systems weather the storm to some extent, there will ultimately be a shortfall. This underscores the urgency to find new sources of revenue. As health systems explore new...

By Catherine Lightfoot, CPA, CHBC, Director of Healthcare at EEPB Believe it or not, financial independence is not just for the super-wealthy or the inherited rich. By focusing on four key areas, practiced consistently, everyone can achieve a measure of wealth and financial security. Wherever you are in your career, making a few modest changes will improve your net worth. In this article, I share the common practices of those I witnessed to have accumulated...

By David Walsh, Associate Director, Healthcare & Life Sciences Strategy, KPMG Stake your claim in the medical device value chain of the future and avoid the commodity trap. While the outlook for medical device companies appears positive, unsustainable healthcare costs and new competitive forces threaten to alter the future industry landscape. If today’s manufacturers fail to stake their claim in the evolving value chain, they risk being caught in the middle and becoming commoditized. The...